Segmental vasodilatory effectiveness of inhaled NO in lungs from chronically hypoxic rats

Respiration Physiology

Volumn 114, Issue 2, 1998, Pages 161-173

  Resta, Thomas C ^a   Sanders, Thomas C ^a   Eichinger, Mark R ^a   Crowley, Mark R ^a   Walker, Benjimen R ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Blood flow, pulmonary, NO; Hypertension, pulmonary, NO; Hypoxia, chronic, effect of NO; Mammals, rat; Mediators, NO

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; HEMOGLOBIN; NITRIC OXIDE;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE; EXTRAVASATION; HYPOXIA; ISOLATED LUNG; LUNG BLOOD FLOW; LUNG CAPILLARY PRESSURE; MALE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REGIONAL PERFUSION; VASODILATATION; VEIN DIAMETER; VEIN DILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADMINISTRATION, INHALATION; ANIMALS; ANOXIA; BLOOD VESSELS; BODY FLUIDS; CHRONIC DISEASE; ERYTHROCYTES; LUNG; MALE; NITRIC OXIDE; PERFUSION; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031790043     PISSN: 00345687     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5687(98)00086-3     Document Type: Article

References (33)

1. Abman S.H., Griebel J.L., Parker D.K., Schmidt J.M., Swanton D., Kinsella J.P. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J. Pediatr. 124:1994;881-888.
2. Adnot S., Kouyoumdjian C., Defouilloy C., Andrivet P., Sediame S., Herigault R., Fratacci M.-D. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am. Rev. Respir. Dis. 148:1993;310-316.
3. Barbera J.A., Roger N., Roca J., Rovira I., Higenbottam T.W., Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet. 347:1996;436-440.
4. Blanch L., Joseph D., Fernandez R., Mas A., Valles J., Diaz E., Baigorri F., Artigas A. Hemodynamic and gas exchange responses to inhalation of nitric oxide in patients with the acute respiratory distress syndrome and in hypoxemic patients with chronic obstructive pulmonary disease. Intensive Care Med. 23:1997;51-57.
5. Channick R.N., Newhart J.W., Johnson F.W., Williams P.J., Auger W.R., Fedullo P.F., Moser K.M. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest. 109:1996;1545-1549.
6. Cohen A.H., Hanson K., Morris K., Fouty B., McMurtry I.F., Clarke W., Rodman D.M. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J. Clin. Invest. 97:1996;172-179.
7. Eichinger M.R., Walker B.R. Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am. J. Physiol. 267:1994;H2413-H2419.
8. Eichinger M.R., Walker B.R. Nitric oxide and cGMP do not affect fluid flux in isolated rat lungs. J. Appl. Physiol. 80:1996;69-76.
9. Fried R., Meyrick B., Rabinovitch M., Reid L. Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J. Appl. Physiol. 55:1983;167-172.
10. Hislop A., Reid L. Normal structure and dimensions of the pulmonary arteries in the rat. J. Anat. 125:1978;71-83.
11. Ichida F., Uese K., Hashimoto I., Hamamichi Y., Tsubata S., Fukahara K., Murakami A., Miyawaki T. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children. J. Cardiol. 29:1997;217-224.
12. Kinsella J.P., Neish S.R., Shaffer E., Abman S.H. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 340:1992;819-820.
13. Lindeborg D.M., Kavanagh B.P., Meurs K.V., Pearl R.G. Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance. J. Appl. Physiol. 78:1995;341-348.
14. Meyrick B., Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation: an ultrastructural study. Lab. Invest. 38:1978;188-200.
15. Meyrick B., Reid L. Ultrastructural features of the distended pulmonary arteries of the normal rat. Anat. Rec. 193:1979;71-98.
16. Meyrick B., Reid L. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia: a quantitative ultrastructural study. Lab. Invest. 42:1980;603-615.
17. A/Q inequalities in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 149:1994;1482-1487.
18. Ou L.-C., Smith R.P. Hemoglobinemai in rats exposed to high altitude. Exp. Hematol. 6:1978;473-478.
19. Rabinovitch M., Gamble W., Nadas A.S., Miettinen O.S., Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236:1979;H818-H827.
20. Reeves, J.T., Herget, J., 1984. Experimental models of pulmonary hypertension. In: Weir, E.K., Reeves, J.T. (Eds.), Pulmonary Hypertension. Futura Publishing Co., New York, pp. 361-391.
21. Resta T.C., Russ R.D., Doyle M.P., Martinez J.M., Walker B.R. Cardiovascular responses to hemorrhage during acute and chronic hypoxia. Am. J. Physiol. 267:1994;R619-R627.
22. Resta, T.C., Walker, B.R., 1994. Orally administered L-arginine does not alter right ventricular hypertrophy in chronically hypoxic rats, Am. J. Physiol. 266, R559-R563.
23. Resta T.C., Walker B.R. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am. J. Physiol. 270:1996;H888-H896.
24. Resta T.C., Gonzales R.J., Dail W.G., Sanders T.C., Walker B.R. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am. J. Physiol. 272:1997;H806-H813.
25. Rimar S., Gillis C.N. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung. J. Appl. Physiol. 78:1995;1745-1749.
26. Roberts J.D., Polander D.M., Lang P., Zapol W.M. Inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Lancet. 340:1992;818-819.
27. Roberts J.D., Lang P., Bigatello L.M., Vlahades G.J., Zapol W.M. Inhaled nitric oxide in congenital heart disease. Circulation. 87:1993;447-453.
28. Roos C.M., Rich G.F., Uncles D.R., Daugherty M.O., Frank D.U. Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs. J. Appl. Physiol. 77:1994;51-57.
29. Rubin, L.J., 1984. Pulmonary hypertension secondary to lung disease. In: Weir, E.K., Reeves, J.T. (Eds.), Pulmonary Hypertension. Futura Publishing Co., New York, pp. 291-320.
30. Russ R.D., Walker B.R. Maintained endothelium-dependent pulmonary vasodilation following chronic hypoxia in the rat. J. Appl. Physiol. 74:1993;339-344.
31. Tod M.L., O'Donnell D.C., Gordon J.B. Sites of inhaled NO-induced vasodilation during hypoxia and U-46619 infusion in isolated lamb lungs. Am. J. Physiol. 268:1995;H1422-H1427.
32. Townsley M.I., Korthuis R.J., Rippe B., Parker J.C., Taylor A.E. Validation of double occlusion method for Pc,i in lungs and skeletal muscle. J. Appl. Physiol. 61:1986;127-132.
33. Yoshida M., Taguchi O., Gabazza E.C., Kobayashi T., Yamakami T., Kobayashi H., Maruyama K., Shima T. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 155:1997;526-529.